The study aimed to determine the multidimensional impact of pruritus, to define the impact on quality of life and to identify the experiences of patients with the symptom.
Methods
A mixed-methods study with sequential quantitative and qualitative method with 57 patients experiencing pruritus in the hepatology and internal medicine clinics.
Results
A pruritus prevalence of 37.7% was found, with a mean score of 19.4 ± 3.4 (0–25) and the daily duration was 18–23 h/day (43.9%). The mean total score of the Liver Disease Symptom Index 2.0 was 66.57 ± 9.13 (0–96). A correlation was found between elevated GGT levels and pruritus. The qualitative content analysis consisted of three main themes: the meaning of pruritus and scratching; impact on quality of life; and ways of coping/dealing with pruritus symptom.
Discussion
The study shows that quantitative and qualitative results concurred that pruritus impairs patient's quality of life in regards to sleep, social isolation, daily living activities, and eating habits.
BeuersUWoltersFOude ElferinkRP. Mechanisms of pruritus in cholestasis: understanding and treating the itch. Nat Rev Gastroenterol Hepatol2023; 20: 26–36.
2.
OedaSTakahashiHYoshidaH, et al.Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res2018; 48: E252–E262.
SanjelBShimW-S. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: a review. Biochim Biophys Acta (Mol Bas Dis2020; 1866: 165958.
5.
AsalFZiadaDWagehA, et al.The correlation between the autotaxin enzyme and pruritus in Egyptian patients suffering from chronic liver disease. Anti-Inflamm Anti-Allergy Agents Med Chem2021; 20: 302–307.
6.
YoshikawaSAsanoTMorinoM, et al.Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride. Sci Rep2021; 11: –8.
7.
MartinMLStassekLBlumSI, et al.Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis. J Patient Reported Outcomes2019; 3: 1–11.
8.
Kido-NakaharaMNakaharaTFurusyoN, et al.Pruritus in chronic liver disease: a questionnaire survey on 216 patients. Acta Derm-Venereol2019; 99: 220–221.
9.
HuesmannMHuesmannTOsadaN, et al.Cholestatic pruritus: a retrospective analysis on clinical characteristics and treatment response. JDDG Journal der Deutschen Dermatologischen Gesellschaft2013; 11: 158–168.
10.
HegadeVSBolierRElferinkRPO, et al.A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Frontline Gastroenterol2016; 7: 158–166.
11.
DüllMMKremerAE. Newer approaches to the management of pruritus in cholestatic liver disease. Curr Hepatol Rep2020; 19: 86–95.
12.
PengJ-KHepgulNHigginsonIJ, et al.Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med2019; 33: 24–36.
13.
YeamCTYoTETanYLC, et al.Complementary and alternative medicine therapies for uremic pruritus-A systematic review of randomized controlled trials. Complement Ther Med2020; 56: 102609.
14.
HirschfieldGBeuersUCorpechotC. Electronic address: easloffice@ easloffice. EU; European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol2017; 67: 145–172.
15.
AlıcıCBKoçZ. Quality of life and satisfaction affect individualized nursing care perceptions in intensive care. Psychol Health Med2020; 25: 148–159.
16.
JinXYKhanTM. Quality of life among patients suffering from cholestatic liver disease-induced pruritus: a systematic review. J Formos Med Assoc2016; 115: 689–702.
17.
MarchesiniGBianchiGAmodioP, et al.Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology2001; 120: 170–178.
18.
RisheEAzarmABergasaNV. Itch in primary biliary cirrhosis: a patients’ perspective. Acta Derm-Venereol2008; 88: 34–37.
19.
WillisDGSullivan-BolyaiSKnaflK, et al.Distinguishing features and similarities between descriptive phenomenological and qualitative description research. West J Nurs Res2016; 38: 1185–1204.
20.
ClarkVLP. Meaningful integration within mixed methods studies: identifying why, what, when, and how. Contemp Educ Psychol2019; 57: 106–111.
21.
ElmanSHynanLGabrielV, et al.The 5-D itch scale: a new measure of pruritus. Br J Dermatol2010; 162: 587–593.
MistikSUtasSFerahbasA, et al.An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol2006; 20: 672–678.
24.
ErsoyNAAkyarİ. Validity and reliability of 5-D itch scale on chronic renal disease patients. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi2018; 9: 455–461.
25.
Van Der PlasSMHansenBEDe BoerJB, et al.The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaire. Qual Life Res2004; 13: 1469–1481.
26.
EraydınA. Kronik karaciğer hastalığı yaşam kalitesi ölçeği 2.0′ın Türk toplumu için geçerlilik ve güvenilirliği. Dokuz Eylül Üniversitesi Tıp Fakültesi Uzmanlık Tezi2013: 1–69.
27.
GraneheimUHLundmanB. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today2004; 24: 105–112.
28.
KremerAEElferinkRPOBeuersU. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol2011; 35: 89–97.
29.
FurqanSKamaniLJabbarA. Skin manifestations in diabetes mellitus. Journal of Ayub Medical College Abbottabad2014; 26: 46–48.
30.
TsengHWGerLPLiangCK, et al.High prevalence of cutaneous manifestations in the elderly with diabetes mellitus: an institution-based cross-sectional study in Taiwan. J Eur Acad Dermatol Venereol2015; 29: 1631–1635.
31.
YagiMTanakaAMiuraK, et al.The assessment of subjective symptoms and patient-reported outcomes in patients with primary biliary cholangitis using PBC-40. Kanzo2016; 57: 457–467.
32.
PuslTBeuersU. Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World J Gastroenterol2006; 12: 3487.
33.
MadanABarthKSBallietWE, et al.Chronic pain among liver transplant candidates. Prog Transplant2012; 22: 379–384.
